FPH releases F&P Visairo hospital under-nose mask for NIV
News Release
STOCK EXCHANGE LISTINGS: NEW ZEALAND (FPH), AUSTRALIA (FPH)
Fisher & Paykel Healthcare releases F&P Visairo
™ hospital under-nose mask for
noninvasive ventilation
Auckland, New Zealand, 17 November 2021 – Fisher & Paykel Healthcare has announced the
launch of F&P Visairo™, a hospital under-nose mask for noninvasive ventilation, in the United
States.
F&P Visairo is a new high-performance under-nose hospital mask with dynamic support
technology. This allows for bridge-free noninvasive ventilation, which eliminates pressure from
the bridge of the nose and clears the way for an open field of vision, without compromising on
stability and performance. Stability wings in the mask frame provide support for the floating seal
to remain comfortable and stable on the patient’s face.
In trials of F&P Visairo, 96 percent of clinicians rated the mask ‘very good’ or ‘good’ for
performance, and 95 percent rated it ‘very good’ or ‘good’ for comfort.
1
“The feedback we have received from clinicians has been impressive,” said Dr Andrew
Somervell, VP Products and Technology for Fisher & Paykel Healthcare.
“For hospital patients who require higher levels of respiratory support without intubation, Visairo
provides a more comfortable experience, so the therapy is more likely to be effective. It sits
comfortably on the face and allows for a clear field of vision, so patients can wear glasses, read
or watch television during their treatment,” said Dr Somervell.
F&P Visairo is currently available in the U.S., New Zealand, Australia, and Europe and will be
released to other regions upon receiving regulatory clearances. The mask is available in three
sizes to correspond to the dimensions of the patient’s nose. Details can be found at
www.fphcare.com/visairo or by contacting your local Fisher & Paykel Healthcare sales
representative.
1
Clinicians' responses were collected at 12 different hospitals in the U.S., Canada and Australia. Data was gathered from at
least 93 responses.
About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and
systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive
sleep apnea. The company’s products are sold in over 120 countries worldwide. For more
information about the company, visit our website www.fphcare.com
.
Authorised by Fisher & Paykel Healthcare Corporation Limited’s Company Secretary.
Media & Investor Contacts:
Karen Knott
GM Corporate Communications
karen.knott@fphcare.co.nz
+64 21 713 911
Hayden Brown
Investor Relations Manager
hayden.brown@fphcare.co.nz
+64 27 807 8073
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- KFL — Kingfish Limited: KFL – December 2021 monthly update2021-12-13
“1 A WORD FROM THE MANAGER In November, Kingfish’s gross performance return was down (3.2%) and the adjusted NAV return was also down (3.2%). This compares with the local market benchmark index return, the S&P/NZX50G, which was down (2.9%). Market Update New Zealand equities,…”
- FBU — Fletcher Building: Fletcher Building FY22 Half Year Results and Dividend2022-02-15
“Fletcher Building Limited, Private Bag 92114, Auckland 1142, 810 Great South Road, Penrose, Auckland 1061, New Zealand Based on our experience in Australia with the COVID-19 Omicron variant, we foresee a potential risk impact on our EBIT in the $25 million to $50 million range.…”
- PFI — Property for Industry Limited: Acquisition of Avondale Industrial Property2021-10-19
“NZX and media announcement — 19 October 2021 Page 1 ACQUISITION OF AVONDALE INDUSTRIAL PROPERTY Property for Industry Limited (PFI, the Company) is pleased to announce the acquisition of an industrial property located at 32 Honan Place in Avondale, Auckland for $3.1…”